A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Zongertinib in the Blood
Clinical trial NCT06028464 · COMPLETED
Trial details
- NCT number
- NCT06028464
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2023-12-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.